2.15Open2.15Pre Close0 Volume336 Open Interest10.00Strike Price0.00Turnover79.31%IV9.04%PremiumOct 18, 2024Expiry Date1.37Intrinsic Value100Multiplier13DDays to Expiry0.78Extrinsic Value100Contract SizeAmericanOptions Type-0.8190Delta0.2090Gamma5.85Leverage Ratio-0.0122Theta-0.0024Rho-4.79Eff Leverage0.0043Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet